
Small molecule protein inhibition with Interdict Bio
14.6.2026
0:00
29:48
In today's episode we are joined by Dr Lawrence Hamann from Interdict Bio! We hear about bioavailable small molecule drugs that can inhibit ribosomal protein synthesis in MYC-dependent cancers. We also learn some tips for people looking to get into a drug development career!
Weitere Episoden von „Dangerous Ideas In Drug Development“



Verpasse keine Episode von “Dangerous Ideas In Drug Development” und abonniere ihn in der kostenlosen GetPodcast App.








